Literature DB >> 27063192

Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse.

B Hechler1,2,3,4, B Maître1,2,3,4, S Magnenat1,2,3,4, V Heim1,2,3,4, M-B El Mdawar1,2,3,4, C Gachet1,2,3,4, H de la Salle1,2,3,4.   

Abstract

UNLABELLED: Essentials Role of platelets in immunological transfusion-related acute lung injury (TRALI) is debated. Immunological TRALI was tested in mice exhibiting severe thrombocytopenia or platelet dysfunction. Platelets are required to prevent lung hemorrhage but not edema formation and respiratory distress. Platelets are dispensable for the initiation and development of TRALI.
SUMMARY: Background Transfusion-related acute lung injury (TRALI) is a serious transfusion-related complication. Previous conflicting studies have indicated that platelets are either crucial or dispensable for TRALI. Objectives To evaluate the role of platelets in major histocompatibility complex (MHC) I-induced-TRALI. Methods Antibody-mediated TRALI was experimentally induced in mice by lipopolysaccharide priming followed by the administration of an anti-MHC I mAb. Results TRALI was tested in the context of severe thrombocytopenia provoked by the administration of diphtheria toxin (DT) in transgenic iDTR mice selectively expressing DT receptor in megakaryocytes. The pathologic responses occurring within the first 10 min following the injection of the anti-MHC I mAb, i.e. the severity of lung edema and the drop in aortic blood oxygenation, were similar in severely thrombocytopenic DT-iDTR and control mice. At later times, mortality was nevertheless increased in DT-iDTR mice, owing to lung hemorrhages. When less severe thrombocytopenia was induced with an antiplatelet mAb, TRALI started and developed similarly as in control mice, but hemorrhages were absent. Furthermore, when platelet functions were defective because of administration of aspirin or clopidogrel, or because of glycoprotein (GP)IIbIIIa deficiency, TRALI still developed but no lung hemorrhages were observed. In contrast, when GPVI was immunodepleted, TRALI still occurred, but was occasionally accompanied by hemorrhages. Conclusions Platelets are dispensable for the initiation and development of MHC I-induced TRALI. Although they do not protect against the disruption of the vascular endothelial cell barrier and the subsequent plasma leakage and edema formation, platelets are essential to prevent more serious damage resulting in hemorrhages in alveoli.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  acute lung injury; blood platelets; blood transfusion; hemorrhage; pulmonary edema; thrombocytopenia

Mesh:

Substances:

Year:  2016        PMID: 27063192     DOI: 10.1111/jth.13335

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  10 in total

1.  T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10.

Authors:  Rick Kapur; Michael Kim; Rukhsana Aslam; Mark J McVey; Arata Tabuchi; Alice Luo; Jonathan Liu; Yuan Li; Shanjeevan Shanmugabhavananthan; Edwin R Speck; Anne Zufferey; George Yousef; Haibo Zhang; Matthew T Rondina; Andrew S Weyrich; Leendert Porcelijn; Wolfgang M Kuebler; Arthur S Slutsky; John W Semple
Journal:  Blood       Date:  2017-02-15       Impact factor: 22.113

Review 2.  Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

3.  Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation.

Authors:  Eveline A N Zeeuw van der Laan; Saskia van der Velden; Arthur E H Bentlage; Mads D Larsen; Thijs L J van Osch; Juk Yee Mok; Giso Brasser; Dionne M Geerdes; Carolien A M Koeleman; Jan Nouta; John W Semple; Leendert Porcelijn; Wim J E van Esch; Manfred Wuhrer; C Ellen van der Schoot; Gestur Vidarsson; Rick Kapur
Journal:  Blood Adv       Date:  2020-08-25

4.  Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse.

Authors:  Siân Lax; Julie Rayes; Surasak Wichaiyo; Elizabeth J Haining; Kate Lowe; Beata Grygielska; Ryan Laloo; Per Flodby; Zea Borok; Edward D Crandall; David R Thickett; Steve P Watson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

Review 5.  Measuring and interpreting platelet-leukocyte aggregates.

Authors:  Michaela Finsterbusch; Waltraud C Schrottmaier; Julia B Kral-Pointner; Manuel Salzmann; Alice Assinger
Journal:  Platelets       Date:  2018-02-20       Impact factor: 3.862

6.  The ATP-gated P2X1 ion channel contributes to the severity of antibody-mediated Transfusion-Related Acute Lung Injury in mice.

Authors:  Marie-Belle El Mdawar; Blandine Maître; Stéphanie Magnenat; Christian Gachet; Béatrice Hechler; Henri de la Salle
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

7.  Platelet FcγRIIA-induced serotonin release exacerbates the severity of transfusion-related acute lung injury in mice.

Authors:  Marie-Belle El Mdawar; Blandine Maître; Stéphanie Magnenat; Florian Tupin; Friederike Jönsson; Christian Gachet; Henri de la Salle; Beatrice Hechler
Journal:  Blood Adv       Date:  2021-12-14

Review 8.  The Role of Complement in Transfusion-Related Acute Lung Injury.

Authors:  Ilse Jongerius; Leendert Porcelijn; Anna E van Beek; John W Semple; C Ellen van der Schoot; Alexander P J Vlaar; Rick Kapur
Journal:  Transfus Med Rev       Date:  2019-10-18

Review 9.  Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment-From Mice to Men.

Authors:  Andreas von Knethen; Ulrike Heinicke; Volker Laux; Michael J Parnham; Andrea U Steinbicker; Kai Zacharowski
Journal:  Biomedicines       Date:  2022-01-04

10.  Complement activation on endothelium initiates antibody-mediated acute lung injury.

Authors:  Simon J Cleary; Nicholas Kwaan; Jennifer J Tian; Daniel R Calabrese; Beñat Mallavia; Mélia Magnen; John R Greenland; Anatoly Urisman; Jonathan P Singer; Steven R Hays; Jasleen Kukreja; Ariel M Hay; Heather L Howie; Pearl Toy; Clifford A Lowell; Craig N Morrell; James C Zimring; Mark R Looney
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.